Protein Aggregation Trend 2026

Protein aggregation occurs when misfolded proteins clump together, forming harmful deposits linked to Alzheimer’s, Parkinson’s, and ALS. In biotech, researchers study this process to develop therapeutic inhibitors and diagnostic tools. Pharmaceutical companies, neuroscientists, and clinicians benefit by targeting these aggregates to slow disease progression. Understanding aggregation also aids vaccine stability and protein-based drug manufacturing, improving treatment outcomes for millions.